Bionexus Gene Lab Corp. (BGLC) at a glance

Bionexus Gene Lab Corp. (BGLC) is a micro-cap Basic Materials company. It trades at $2, with a -54.7% profit margin and revenue decline of 98.9%. It does not pay a dividend. Vestovix scores it 27/100 overall. Its strongest dimension is Value (48/100) and its weakest is Growth (11/100). It carries above-market volatility, so expect larger swings.

Price

$2.00

Market cap

$5.2M

P/E ratio

n/a

Dividend yield

None

Beta

2.19

52-week range

$1.07 to $15.60